Back to results
US 6,900,302 B2Granted
Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
AssigneeChiron Corporation
InventorsGiuseppe Teti, Luciano Polonelli
Life of this patent
Estimating the term…
Abstract
The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the development of vaccines that are effective against diseases caused by these pathogens.
Claims12
An isolated nucleic acid molecule which encodes an scFv fragment that is capable of eliciting a type III capsular polysaccharide-specific protective immune response against group B Streptococcus.
Dependencies are inferred from the claim text.